Skip to content

A study to verify the effects of consumption of the test food on anti-aging (blood NAD+, skin, sleep) in healthy Japanese: an open-label study

A study to verify the effects of consumption of the test food on anti-aging (blood NAD+, skin, sleep) in healthy Japanese: an open-label study - A study to verify the effects of consumption of the test food on anti-aging (blood NAD+, skin, sleep) in healthy Japanese

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000061140
Enrollment
20
Registered
2026-04-02
Start date
2026-04-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese

Interventions

Duration: 99 days Test product: Cell regeneration, Cell repair Administration: Both Cell regeneration and Cell repair are taken daily. Take four tablets of Cell regeneration 10 minutes before the fi

Sponsors

WELLCREATE Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Japanese 2. Healthy individuals 3. "Women between 30 and 40 years old whose menstrual cycle has been between 25 and 35 days in the past six months" or "Men between 35 and 55 years old"

Exclusion criteria

Exclusion criteria: Individuals who 1.are undergoing medical treatment or have a medical history of malignant tumor, heart failure, or myocardial infarction 2.have a pacemaker or an ICD 3.are currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, chronic kidney disease, cerebrovascular disorder, rheumatic disease, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4.are taking "Foods for Specified Health Uses" or "Foods with Functional Claims" 5.are taking or using medications or supplements 6.usually take food/beverage containing functional ingredients which may influence skin (such as GABA, isoflavones, lactic acid bacteria, bifidobacteria, EPA, DHA, astaxanthin, glucosylceramide, proteoglycans, piceatannol, lycoperosides, collagen peptide) 7.are allergic to medicines or foods related to the test product (particularly, apples) 8.have mental health issues such as depression disorder, ADHD, or other issues 9.have irregular sleeping time or habit due to work such as a late-night shift 10.live with their infants less than one year old 11.sleep with their children (1 to 6 years old) 12.live with requiring long-term care persons 13.sleep with more than one person 14.have irregular lifestyles 15.are undergoing medical treatment for chronic fatigue syndrome or menopausal syndrome 16.have been diagnosed with atopic dermatitis 17.habitually receive skincare treatment or use instruments for beauty treatment 18.drink to excess every day 19.have undergone cosmetic surgery 20.are pregnant, lactating, or planning to become pregnant during this study 21.have participated in other clinical studies within 28 days before informed consent, or plan to participate in another study during this study 22.are judged as ineligible to participate in this study by the physician

Design outcomes

Primary

MeasureTime frame
1. OSA sleep inventory MA version 2. Moisture of the skin 3. Viscoelasticity of the skin 4. Blood NAD+ 5. Skin tone 6. Microscope 7. Body composition

Secondary

MeasureTime frame
1. Individuals who experienced adverse events 2. Individuals whose urinalysis and peripheral blood test values were within the reference range at screening but became outside the reference range after intervention 3. Body composition, urinalysis, and peripheral blood test

Countries

Japan

Contacts

Public ContactNaoko Suzuki

ORTHOMEDICO Inc. R&D Department

nao@orthomedico.jp03-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026